IL22 and cancer: Knockdown of HK2 by siRNA attenuated the promotion of IL-22 on glucose consumption and lactate production (Figure 3D-3G), indicating that HK2 is a functional downstream target of IL-22 in facilitating aerobic glycolysis of cancer cells.